Robert T. Greenlee
National Institutes of Health · 188 works · 17,116 citations · h-index 43
Top works
- Cancer statistics, 2000
- Cancer Statistics, 2001
- Long-term trends in cancer mortality in the United States, 1930-1998
- The Use of Computed Tomography in Pediatrics and the Associated Radiation Exposure and Estimated Cancer Risk
- Use of Diagnostic Imaging Studies and Associated Radiation Exposure for Patients Enrolled in Large Integrated Health Care Systems, 1996-2010
- Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival
- Effectiveness of Inactivated Influenza Vaccines Varied Substantially with Antigenic Match from the 2004–2005 Season to the 2006–2007 Season
- Trends in Use of Medical Imaging in US Health Care Systems and in Ontario, Canada, 2000-2016
- Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival
- Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial
- Results From Four Rounds of Ovarian Cancer Screening in a Randomized Trial
- Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute’s PROSPR Consortium
- Differences in preventive screening rates in Wisconsin farm and non-farm resident women.
- Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992-1997
- The Occurrence of Rare Cancers in U.S. Adults, 1995–2004
- Screening Colonoscopy and Risk for Incident Late-Stage Colorectal Cancer Diagnosis in Average-Risk Adults
- The Cardiovascular Research Network
- Developmental disorders of the lymphatic system.
- Association of Single- vs Dual-Chamber ICDs With Mortality, Readmissions, and Complications Among Patients Receiving an ICD for Primary Prevention
- Prevalence, incidence, and natural history of simple ovarian cysts among women >55 years old in a large cancer screening trial